Weight-loss jab could be made for $3 a month, study finds
The Guardian World
by Kat Lay, Global health corespondentMarch 6, 2026
Cheap semaglutide, the drug in Ozempic and Wegovy, could help millions with diabetes and obesity in 160 countries
Weight-loss jabs such as Wegovy and Ozempic could be made for just $3 a month, according to new analysis, potentially making the treatment available to millions in poorer countries as patents expire.
More than a billion people live with obesity worldwide, with rates rising fast in lower-income nations as they shift to westernised diets and more sedentary lifestyles.
Continue reading...
Verticals
worldpolitics
Originally published on The Guardian World on 3/6/2026